One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Record caution: Safety update: this historical RX extract must be read with the FDA 2021 expanded warning. No reduced-dose renal safety strategy is established.
The historical RX source emphasizes critically ill patients and sepsis. The FDA 2021 action additionally addresses surgical and blunt-trauma populations and availability of adequate alternatives.
What to reconcile: Read the regulatory card before considering the historical product instructions. A lower dose or absence of sepsis does not establish renal safety. Confirm the current exact label and local policy.
Open this note and its source referencesFDA required expanded boxed warnings for hydroxyethyl starch products in July 2021. The risks include mortality, acute kidney injury including renal-replacement therapy, and excess bleeding in surgical patients, plus mortality and acute kidney injury in blunt-trauma patients. FDA advises against use unless an adequate alternative treatment is unavailable.
This safety action extends beyond an older warning limited to critically ill adults or sepsis. It is a regulatory restriction, not a renal dose-reduction strategy or proof that reduced exposure avoids the risk.
RDM38-professional-hetastarch-hespan-52c3f16137-C1 · Source locator: FDA safety communication: strengthened boxed warning and clinician recommendations
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=hetastarch-hespan&s1=RDM38-professional-hetastarch-hespan-52c3f16137&h1=3803b491e2c40896ec3f489f5f84ae4c6832d990105473c92cc9f89d04ac7ec9